SEI Investments’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SNDX
KCM
SEI Investments's SNDX Position: Q3 2026 in Review
SEI Investments increased its Syndax Pharmaceuticals (SNDX) stake by 5.7% in Q3 2026, buying an estimated $222K and bringing the position to 204,121 shares worth $3.84M. The position accounts for ﹤0.01% of the portfolio, ranked #1595.
SEI Investments first reported a position in SNDX in Q1 2019 and has held it in 17 quarters since. The position peaked at $5.08M in Q1 2026. 237 funds tracked by Wall St. Rank hold SNDX as of Q3 2026.
- SEI Investments held 204,121 shares of Syndax Pharmaceuticals worth $3.84M as of Q3 2026.
- SEI Investments bought 10,987 Syndax Pharmaceuticals shares in Q3 2026, an estimated $222K.
- Syndax Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #1595 holding.
- SEI Investments first reported a position in Syndax Pharmaceuticals in Q1 2019 and has held it in 17 quarters since.
- SEI Investments's Syndax Pharmaceuticals position peaked at $5.08M in Q1 2026.
- 237 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.